|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-9-13
|
|
pubmed:abstractText |
To investigate the dosing patterns and treatment costs of erythropoietic agents in adult (>or= 18 years of age) cancer patients newly initiated on epoetin alfa (EPO) or darbepoetin alfa (DARB) in managed care organizations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0300-7995
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1623-31
|
|
pubmed:meshHeading |
pubmed-meshheading:16968565-Adult,
pubmed-meshheading:16968565-Aged,
pubmed-meshheading:16968565-Cohort Studies,
pubmed-meshheading:16968565-Drug Costs,
pubmed-meshheading:16968565-Drug Therapy,
pubmed-meshheading:16968565-Erythropoietin,
pubmed-meshheading:16968565-Female,
pubmed-meshheading:16968565-Humans,
pubmed-meshheading:16968565-Male,
pubmed-meshheading:16968565-Managed Care Programs,
pubmed-meshheading:16968565-Middle Aged,
pubmed-meshheading:16968565-Neoplasms,
pubmed-meshheading:16968565-Office Visits,
pubmed-meshheading:16968565-Outpatients,
pubmed-meshheading:16968565-Physician's Role,
pubmed-meshheading:16968565-Retrospective Studies
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.
|
|
pubmed:affiliation |
Groupe d'Analyse, Ltée, Montréal, Québec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
